Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 51.5B | 48.9B | 41.9B | 43.1B |
Cost of revenue | 29.3B | 27.3B | 22.8B | 23.6B |
Gross profit | 22.2B | 21.6B | 19.0B | 19.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.1B | 7.0B | 5.5B | 5.2B |
Operating income | 10.6B | 10.2B | 9.1B | 10.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 155.4M | 133.9M | 131.4M | 122.7M |
Other income expense | — | — | — | — |
Pretax income | 16.7B | 14.6B | 13.6B | 14.4B |
Tax provision | 3.1B | 2.9B | 2.6B | 3.4B |
Net income | 13.6B | 11.7B | 11.0B | 11.0B |
Basic EPS | — | 42.7 | 40.2 | 40.2 |
Diluted EPS | — | 42.6 | 40.1 | 40.1 |
Basic average shares | — | 274.1M | 274.1M | 273.9M |
Diluted average shares | — | 274.7M | 274.7M | 274.6M |
EBITDA | 18.9B | 16.5B | 15.6B | 16.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |